BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 17169300)

  • 21. Glucose transport by acinar cells in rat parotid glands.
    Jurysta C; Nicaise C; Cetik S; Louchami K; Malaisse WJ; Sener A
    Cell Physiol Biochem; 2012; 29(3-4):325-30. PubMed ID: 22508040
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The role of SLC2A1 mutations in myoclonic astatic epilepsy and absence epilepsy, and the estimated frequency of GLUT1 deficiency syndrome.
    Larsen J; Johannesen KM; Ek J; Tang S; Marini C; Blichfeldt S; Kibaek M; von Spiczak S; Weckhuysen S; Frangu M; Neubauer BA; Uldall P; Striano P; Zara F; ; Kleiss R; Simpson M; Muhle H; Nikanorova M; Jepsen B; Tommerup N; Stephani U; Guerrini R; Duno M; Hjalgrim H; Pal D; Helbig I; Møller RS
    Epilepsia; 2015 Dec; 56(12):e203-8. PubMed ID: 26537434
    [TBL] [Abstract][Full Text] [Related]  

  • 23. From splitting GLUT1 deficiency syndromes to overlapping phenotypes.
    Hully M; Vuillaumier-Barrot S; Le Bizec C; Boddaert N; Kaminska A; Lascelles K; de Lonlay P; Cances C; des Portes V; Roubertie A; Doummar D; LeBihannic A; Degos B; de Saint Martin A; Flori E; Pedespan JM; Goldenberg A; Vanhulle C; Bekri S; Roubergue A; Heron B; Cournelle MA; Kuster A; Chenouard A; Loiseau MN; Valayannopoulos V; Chemaly N; Gitiaux C; Seta N; Bahi-Buisson N
    Eur J Med Genet; 2015 Sep; 58(9):443-54. PubMed ID: 26193382
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The clinical and biochemical hallmarks generally associated with GLUT1DS may be caused by defects in genes other than SLC2A1.
    Sánchez-Lijarcio O; Yubero D; Leal F; Couce ML; González Gutiérrez-Solana L; López-Laso E; García-Cazorla À; Pías-Peleteiro L; de Azua Brea B; Ibáñez-Micó S; Mateo-Martínez G; Troncoso-Schifferli M; Witting-Enriquez S; Ugarte M; Artuch R; Pérez B
    Clin Genet; 2022 Jul; 102(1):40-55. PubMed ID: 35388452
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Temporal characterization of cardiac expression of glucose transporters SGLT and GLUT in an experimental model of myocardial infarction.
    Sánchez-Más J; Saura-Guillén E; Asensio-López MC; Soriano-Filiu Á; Carmen Sánchez-Pérez M; Hernandez-Martinez AM; Lax A; Pascual-Figal D
    Diabetes Metab; 2019 Apr; 45(2):201-204. PubMed ID: 29097004
    [No Abstract]   [Full Text] [Related]  

  • 26. Glucose transporter-1 deficiency syndrome: the expanding clinical and genetic spectrum of a treatable disorder.
    Leen WG; Klepper J; Verbeek MM; Leferink M; Hofste T; van Engelen BG; Wevers RA; Arthur T; Bahi-Buisson N; Ballhausen D; Bekhof J; van Bogaert P; Carrilho I; Chabrol B; Champion MP; Coldwell J; Clayton P; Donner E; Evangeliou A; Ebinger F; Farrell K; Forsyth RJ; de Goede CG; Gross S; Grunewald S; Holthausen H; Jayawant S; Lachlan K; Laugel V; Leppig K; Lim MJ; Mancini G; Marina AD; Martorell L; McMenamin J; Meuwissen ME; Mundy H; Nilsson NO; Panzer A; Poll-The BT; Rauscher C; Rouselle CM; Sandvig I; Scheffner T; Sheridan E; Simpson N; Sykora P; Tomlinson R; Trounce J; Webb D; Weschke B; Scheffer H; Willemsen MA
    Brain; 2010 Mar; 133(Pt 3):655-70. PubMed ID: 20129935
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Brain microvasculature defects and Glut1 deficiency syndrome averted by early repletion of the glucose transporter-1 protein.
    Tang M; Gao G; Rueda CB; Yu H; Thibodeaux DN; Awano T; Engelstad KM; Sanchez-Quintero MJ; Yang H; Li F; Li H; Su Q; Shetler KE; Jones L; Seo R; McConathy J; Hillman EM; Noebels JL; De Vivo DC; Monani UR
    Nat Commun; 2017 Jan; 8():14152. PubMed ID: 28106060
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A Protein Kinase C Phosphorylation Motif in GLUT1 Affects Glucose Transport and is Mutated in GLUT1 Deficiency Syndrome.
    Lee EE; Ma J; Sacharidou A; Mi W; Salato VK; Nguyen N; Jiang Y; Pascual JM; North PE; Shaul PW; Mettlen M; Wang RC
    Mol Cell; 2015 Jun; 58(5):845-53. PubMed ID: 25982116
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Usefulness of diagnostic tools in a GLUT1 deficiency syndrome patient with 2 inherited mutations.
    Dozières-Puyravel B; Zaman S; Petrou S; François L; Vuillaumier-Barrot S; Mochel F; Gras D; Auvin S
    Brain Dev; 2019 Oct; 41(9):808-811. PubMed ID: 31196579
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Glucose transporter type 1 deficiency syndrome with carbohydrate-responsive symptoms but without epilepsy.
    Koy A; Assmann B; Klepper J; Mayatepek E
    Dev Med Child Neurol; 2011 Dec; 53(12):1154-6. PubMed ID: 21838819
    [TBL] [Abstract][Full Text] [Related]  

  • 31. New Paradigm for the Treatment of Glucose Transporter 1 Deficiency Syndrome: Low Glycemic Index Diet and Modified High Amylopectin Cornstarch.
    Almuqbil M; Go C; Nagy LL; Pai N; Mamak E; Mercimek-Mahmutoglu S
    Pediatr Neurol; 2015 Sep; 53(3):243-6. PubMed ID: 26216499
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Facilitated glucose transporter protein type 1 (GLUT1) deficiency syndrome: impaired glucose transport into brain-- a review.
    Klepper J; Voit T
    Eur J Pediatr; 2002 Jun; 161(6):295-304. PubMed ID: 12029447
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clinical presentation, EEG studies, and novel mutations in two cases of GLUT1 deficiency syndrome in Japan.
    Ito Y; Gertsen E; Oguni H; Nakayama T; Matsuo M; Funatsuka M; Voit T; Klepper J; Osawa M
    Brain Dev; 2005 Jun; 27(4):311-7. PubMed ID: 15862198
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A 23 years follow-up study identifies GLUT1 deficiency syndrome initially diagnosed as complicated hereditary spastic paraplegia.
    Diomedi M; Gan-Or Z; Placidi F; Dion PA; Szuto A; Bengala M; Rouleau GA; Gigli GL
    Eur J Med Genet; 2016 Nov; 59(11):564-568. PubMed ID: 27725288
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Milder phenotypes of glucose transporter type 1 deficiency syndrome.
    Anand G; Padeniya A; Hanrahan D; Scheffer H; Zaiwalla Z; Cox D; Mann N; Hewertson J; Price S; Nemeth A; Arsov T; Scheffer I; Jayawant S; Pike M; McShane T
    Dev Med Child Neurol; 2011 Jul; 53(7):664-8. PubMed ID: 21649651
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Atypical Manifestations in Glut1 Deficiency Syndrome.
    De Giorgis V; Varesio C; Baldassari C; Piazza E; Olivotto S; Macasaet J; Balottin U; Veggiotti P
    J Child Neurol; 2016 Aug; 31(9):1174-80. PubMed ID: 27250207
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Favourable response to ketogenic dietary therapies: undiagnosed glucose 1 transporter deficiency syndrome is only one factor.
    Schoeler NE; Cross JH; Drury S; Lench N; McMahon JM; MacKay MT; Scheffer IE; Sander JW; Sisodiya SM
    Dev Med Child Neurol; 2015 Oct; 57(10):969-76. PubMed ID: 25914049
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Functional studies of the T295M mutation causing Glut1 deficiency: glucose efflux preferentially affected by T295M.
    Wang D; Yang H; Shi L; Ma L; Fujii T; Engelstad K; Pascual JM; De Vivo DC
    Pediatr Res; 2008 Nov; 64(5):538-43. PubMed ID: 18614966
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Somatic mosaicism for a SLC2A1 mutation: implications for genetic counseling for GLUT1 deficiency syndrome.
    Takahashi S; Matsufuji M; Yonee C; Tsuru H; Sano N; Oguni H
    Clin Genet; 2017 Jun; 91(6):932-933. PubMed ID: 28124377
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Implications of aberrant temperature-sensitive glucose transport via the glucose transporter deficiency mutant (GLUT1DS) T295M for the alternate-access and fixed-site transport models.
    Cunningham P; Naftalin RJ
    J Membr Biol; 2013 Jun; 246(6):495-511. PubMed ID: 23740044
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.